Data as of Apr 17
| +0.04 / +0.31%|
The 2 analysts offering 12-month price forecasts for Depomed Inc have a median target of 16.00, with a high estimate of 18.00 and a low estimate of 14.00. The median estimate represents a +24.32% increase from the last price of 12.87.
The current consensus among 3 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.